Pseudomonas aeruginosa Exotoxin A Reduces Chemoresistance of Oral Squamous Carcinoma Cell via Inhibition of Heat Shock Proteins 70 (HSP70)
Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacteria...
Saved in:
Published in | Yonsei medical journal Vol. 51; no. 5; pp. 708 - 716 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Yonsei University College of Medicine
01.09.2010
연세대학교의과대학 |
Subjects | |
Online Access | Get full text |
ISSN | 0513-5796 1976-2437 1976-2437 |
DOI | 10.3349/ymj.2010.51.5.708 |
Cover
Abstract | Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9).
The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis.
While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint.
Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells. |
---|---|
AbstractList | Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9).
The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis.
While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint.
Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells. Purpose: Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9). Materials and Methods:The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT,Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis. Results: While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint. Conclusion: Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells. KCI Citation Count: 4 Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9).PURPOSEOral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat shock proteins 70 (HSP70) in cancer cells are known to confer resistance to apoptosis. Since recent advances in the understanding of bacterial toxins have produced new strategies for the treatment of cancers, we investigated the effect of Pseudomonas aeruginosa exotoxin A (PEA) on HSP70 expression and induction of apoptosis in chemoresistant OSCC cell line (YD-9).The apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis.MATERIALS AND METHODSThe apoptotic effect of PEA on chemoresistant YD-9 cells was confirmed by MTT, Hoechst and TUNEL stains, DNA electrophoresis, and Western blot analysis.While YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint.RESULTSWhile YD-9 cells showed high resistance to chemotherapeutic agents such as etoposide and 5-fluorouraci (5-FU), HSP70 antisense oligonucelotides sensitized chemoresistant YD-9 cells to etoposide and 5-FU. On the other hand, PEA significantly decreased the viability of YD-9 cells by deteriorating the HSP70-relating protecting system through inhibition of HSP70 expression and inducing apoptosis in YD-9 cells. Apoptotic manifestations were evidenced by changes in nuclear morphology, generation of DNA fragmentation, and activation of caspases. While p53, p21, and E2F-1 were upregulated, cdk2 and cyclin B were downregulated by PEA treatment, suggesting that PEA caused cell cycle arrest at the G2/M checkpoint.Therefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells.CONCLUSIONTherefore, these results indicate that PEA reduced the chemoresistance through inhibition of HSP70 expression and also induced apoptosis in chemoresistant YD-9 cells. |
Author | Park, Sang Rye Park, Bong Soo Oh, Kyu Seon Gil, Young Gi Kim, Gyoo Cheon Lee, Kyoung Duk Kim, Uk Kyu |
AuthorAffiliation | 1 Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea 3 Department of Oral and Maxillofacial Surgery, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea 2 Department of Anatomy, College of Medicine, Kosin University, Busan, Korea 4 Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA |
AuthorAffiliation_xml | – name: 3 Department of Oral and Maxillofacial Surgery, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea – name: 1 Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea – name: 4 Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA – name: 2 Department of Anatomy, College of Medicine, Kosin University, Busan, Korea |
Author_xml | – sequence: 1 givenname: Sang Rye surname: Park fullname: Park, Sang Rye organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea – sequence: 2 givenname: Kyoung Duk surname: Lee fullname: Lee, Kyoung Duk organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea – sequence: 3 givenname: Uk Kyu surname: Kim fullname: Kim, Uk Kyu organization: Department of Oral and Maxillofacial Surgery, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea – sequence: 4 givenname: Young Gi surname: Gil fullname: Gil, Young Gi organization: Department of Anatomy, College of Medicine, Kosin University, Busan, Korea – sequence: 5 givenname: Kyu Seon surname: Oh fullname: Oh, Kyu Seon organization: Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA – sequence: 6 givenname: Bong Soo surname: Park fullname: Park, Bong Soo organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea – sequence: 7 givenname: Gyoo Cheon surname: Kim fullname: Kim, Gyoo Cheon organization: Department of Oral Anatomy, School of Dentistry, Research Institute for Oral Biotechnology, Pusan National University, Yangsan, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20635445$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001470608$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9ks1OGzEUha2KqgTaB-im8q50kfT6bzyzqRRFlERCIiJ0bTkeDzGZscGeQfAKPDUOoajtoqsry9851773HKEDH7xF6DOBCWO8-v7Y3Uwo5JMgEzGRUL5DI1LJYkw5kwdoBIKwsZBVcYiOUroBoJIA_YAOKRRMcC5G6GmZ7FCHLnidsLZxuHY-JI1PH0IfHpzHU3xp68HYhGcb24Vok0u99sbi0OCLqFu8uht0F4YM6GiyutN4ZtsW3zuNF37j1q53we_wudU9Xm2C2eJlDL11PmEJ-GS-Wkr49hG9b3Sb7KfXeox-_Ty9ms3H5xdni9n0fGxYWfZjXZeSMFrYuuGScbCwJhQ4CM5owy2TlJcGOK9pkW8qwgGgoZARClUeDDtGJ3tfHxu1NU4F7V7qdVDbqKaXVwvFGCmrMqM_9ujtsO5sbazv84_VbXSdjo8vwr9vvNtkm3tFKyhLAdng66tBDHeDTb3qXDJ5OtrbPDIlGavKQpAqk1_-bPXW4_eqMkD2gIkhpWibN4SA2sVB5TioXRyUIEqoHIeskf9ojOv1bh35ta79j_IZ7dK5ig |
CitedBy_id | crossref_primary_10_3892_ijo_2013_1772 crossref_primary_10_1128_iai_00437_22 crossref_primary_10_1371_journal_pone_0091947 crossref_primary_10_3892_or_2013_2372 crossref_primary_10_3346_jkms_2025_40_e30 crossref_primary_10_3390_ijms14024185 crossref_primary_10_1080_21688370_2018_1479568 |
Cites_doi | 10.1111/j.1582-4934.2008.00575.x 10.4049/jimmunol.161.10.5745 10.1124/jpet.109.155549 10.1073/pnas.0538044100 10.1007/s00384-007-0307-x 10.4161/cc.5.22.3448 10.1126/science.1117105 10.1517/13543780902752463 10.1016/S0962-8924(00)01874-2 10.1038/sj.onc.1208495 10.1093/carcin/bgi025 10.1073/pnas.0408229102 10.1007/s10059-009-0126-8 10.1016/j.toxicon.2003.08.003 10.1002/hed.20319 10.1101/gad.813200 10.1007/s00262-002-0353-8 10.1038/emm.2005.48 10.1038/ncb868 10.1016/S1368-8375(99)00079-2 10.1042/bst0290696 10.1016/j.molimm.2007.08.013 10.1158/0008-5472.CAN-08-2725 10.1084/jem.191.6.1005 10.1080/09553000802662595 10.1016/j.aodf.2007.10.014 10.1208/aapsj080363 10.1016/j.ejphar.2007.07.039 10.1007/s00726-007-0536-x 10.1002/ijc.20371 10.1111/j.1538-7836.2005.01110.x 10.1182/blood-2003-04-1317 10.1073/pnas.052707699 10.1074/jbc.M405594200 10.1074/jbc.M906383199 10.1016/j.pharmthera.2003.11.004 10.1016/j.dnarep.2004.03.034 10.1074/jbc.M200805200 10.1128/IAI.73.8.5115-5126.2005 10.1016/j.oraloncology.2003.09.012 |
ContentType | Journal Article |
Copyright | Copyright: Yonsei University College of Medicine 2010 2010 |
Copyright_xml | – notice: Copyright: Yonsei University College of Medicine 2010 2010 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3349/ymj.2010.51.5.708 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1976-2437 |
EndPage | 716 |
ExternalDocumentID | oai_kci_go_kr_ARTI_331898 PMC2908850 20635445 10_3349_ymj_2010_51_5_708 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 123 29R 2WC 36B 5-W 53G 5RE 8JR 8XY 9ZL AAYXX ACYCR ADBBV ADRAZ AEGXH AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION CS3 DIK DU5 E3Z EBD EF. EMB EMOBN F5P GROUPED_DOAJ GX1 HYE KQ8 L7B M48 MK0 O5R O5S OK1 OVT P2P PGMZT RNS RPM SV3 TR2 X7M XSB ZGI ZXP CGR CUY CVF ECM EIF NPM 7X8 5PM M~E |
ID | FETCH-LOGICAL-c388t-ad871326edf47340e0b120405432f4e37248c044d260b1914000f202042092433 |
IEDL.DBID | M48 |
ISSN | 0513-5796 1976-2437 |
IngestDate | Tue Nov 21 21:08:30 EST 2023 Thu Aug 21 14:29:33 EDT 2025 Fri Jul 11 05:18:27 EDT 2025 Mon Jul 21 05:52:31 EDT 2025 Thu Apr 24 23:03:45 EDT 2025 Tue Jul 01 04:02:08 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c388t-ad871326edf47340e0b120405432f4e37248c044d260b1914000f202042092433 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000409.2010.51.5.005 http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0311120100510050708 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3349/ymj.2010.51.5.708 |
PMID | 20635445 |
PQID | 733986519 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_331898 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2908850 proquest_miscellaneous_733986519 pubmed_primary_20635445 crossref_primary_10_3349_ymj_2010_51_5_708 crossref_citationtrail_10_3349_ymj_2010_51_5_708 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-09-01 |
PublicationDateYYYYMMDD | 2010-09-01 |
PublicationDate_xml | – month: 09 year: 2010 text: 2010-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Yonsei medical journal |
PublicationTitleAlternate | Yonsei Med J |
PublicationYear | 2010 |
Publisher | Yonsei University College of Medicine 연세대학교의과대학 |
Publisher_xml | – name: Yonsei University College of Medicine – name: 연세대학교의과대학 |
References | Rashmi (10.3349/ymj.2010.51.5.708_ref6) 2005; 26 Stevens (10.3349/ymj.2010.51.5.708_ref43) 2004; 3 Pastan (10.3349/ymj.2010.51.5.708_ref14) 2003; 52 D'Silva (10.3349/ymj.2010.51.5.708_ref1) 2007; 100 Decker (10.3349/ymj.2010.51.5.708_ref22) 2004; 103 Hsu (10.3349/ymj.2010.51.5.708_ref26) 2004; 40 Endo-Munoz (10.3349/ymj.2010.51.5.708_ref39) 2009; 69 10.3349/ymj.2010.51.5.708_ref33 Thant (10.3349/ymj.2010.51.5.708_ref36) 2008; 28 Tong (10.3349/ymj.2010.51.5.708_ref3) 2000; 36 Li (10.3349/ymj.2010.51.5.708_ref9) 2009; 13 Grivicich (10.3349/ymj.2010.51.5.708_ref10) 2007; 22 Lee (10.3349/ymj.2010.51.5.708_ref16) 2005; 73 Spierings (10.3349/ymj.2010.51.5.708_ref4) 2005; 310 Harbour (10.3349/ymj.2010.51.5.708_ref38) 2000; 14 Sreedhar (10.3349/ymj.2010.51.5.708_ref7) 2004; 101 Azuma (10.3349/ymj.2010.51.5.708_ref25) 2004; 24 Li (10.3349/ymj.2010.51.5.708_ref29) 2000; 275 Nahle (10.3349/ymj.2010.51.5.708_ref40) 2002; 4 Furukawa (10.3349/ymj.2010.51.5.708_ref42) 2002; 277 Garrido (10.3349/ymj.2010.51.5.708_ref8) 2006; 5 (10.3349/ymj.2010.51.5.708_ref18) 2008; 42 Jenkins (10.3349/ymj.2010.51.5.708_ref28) 2004; 279 Andersson (10.3349/ymj.2010.51.5.708_ref21) 2004; 112 Meyn (10.3349/ymj.2010.51.5.708_ref31) 2009; 85 Oancea (10.3349/ymj.2010.51.5.708_ref35) 2006; 129 Bickels (10.3349/ymj.2010.51.5.708_ref11) 2002; 4 Cho (10.3349/ymj.2010.51.5.708_ref17) 2003; 42 Crowe (10.3349/ymj.2010.51.5.708_ref2) 2006; 28 Schümann (10.3349/ymj.2010.51.5.708_ref27) 1998; 161 Ismail (10.3349/ymj.2010.51.5.708_ref45) 2007; 575 Moretto (10.3349/ymj.2010.51.5.708_ref32) 2009; 18 Kreitman (10.3349/ymj.2010.51.5.708_ref20) 2006; 8 Lee (10.3349/ymj.2010.51.5.708_ref23) 2005; 37 Beere (10.3349/ymj.2010.51.5.708_ref5) 2001; 11 Koo (10.3349/ymj.2010.51.5.708_ref15) 2002; 99 Zhang (10.3349/ymj.2010.51.5.708_ref24) 2008; 45 Halaban (10.3349/ymj.2010.51.5.708_ref41) 2000; 191 Li (10.3349/ymj.2010.51.5.708_ref44) 2003; 100 Alley (10.3349/ymj.2010.51.5.708_ref13) 2009; 330 Gabai (10.3349/ymj.2010.51.5.708_ref30) 2005; 24 Marra (10.3349/ymj.2010.51.5.708_ref19) 2007; 33 Zacharski (10.3349/ymj.2010.51.5.708_ref12) 2005; 3 Wong (10.3349/ymj.2010.51.5.708_ref37) 2004; 101 Creagh (10.3349/ymj.2010.51.5.708_ref34) 2001; 29 |
References_xml | – volume: 13 start-page: 4540 year: 2009 ident: 10.3349/ymj.2010.51.5.708_ref9 publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2008.00575.x – volume: 24 start-page: 1449 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref25 publication-title: Int J Oncol – volume: 161 start-page: 5745 year: 1998 ident: 10.3349/ymj.2010.51.5.708_ref27 publication-title: J Immunol doi: 10.4049/jimmunol.161.10.5745 – volume: 330 start-page: 932 year: 2009 ident: 10.3349/ymj.2010.51.5.708_ref13 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.109.155549 – volume: 100 start-page: 2674 year: 2003 ident: 10.3349/ymj.2010.51.5.708_ref44 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0538044100 – volume: 22 start-page: 1201 year: 2007 ident: 10.3349/ymj.2010.51.5.708_ref10 publication-title: Int J Colorectal Dis doi: 10.1007/s00384-007-0307-x – volume: 5 start-page: 2592 year: 2006 ident: 10.3349/ymj.2010.51.5.708_ref8 publication-title: Cell Cycle doi: 10.4161/cc.5.22.3448 – volume: 310 start-page: 66 year: 2005 ident: 10.3349/ymj.2010.51.5.708_ref4 publication-title: Science doi: 10.1126/science.1117105 – volume: 18 start-page: 311 year: 2009 ident: 10.3349/ymj.2010.51.5.708_ref32 publication-title: Expert Opin Investig Drugs doi: 10.1517/13543780902752463 – volume: 11 start-page: 6 year: 2001 ident: 10.3349/ymj.2010.51.5.708_ref5 publication-title: Trends Cell Biol doi: 10.1016/S0962-8924(00)01874-2 – volume: 4 start-page: 471 year: 2002 ident: 10.3349/ymj.2010.51.5.708_ref11 publication-title: Isr Med Assoc J – volume: 24 start-page: 3328 year: 2005 ident: 10.3349/ymj.2010.51.5.708_ref30 publication-title: Oncogene doi: 10.1038/sj.onc.1208495 – volume: 26 start-page: 713 year: 2005 ident: 10.3349/ymj.2010.51.5.708_ref6 publication-title: Carcinogenesis doi: 10.1093/carcin/bgi025 – volume: 101 start-page: 17783 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref37 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0408229102 – ident: 10.3349/ymj.2010.51.5.708_ref33 doi: 10.1007/s10059-009-0126-8 – volume: 28 start-page: 3579 year: 2008 ident: 10.3349/ymj.2010.51.5.708_ref36 publication-title: Anticancer Res – volume: 42 start-page: 601 year: 2003 ident: 10.3349/ymj.2010.51.5.708_ref17 publication-title: Toxicon doi: 10.1016/j.toxicon.2003.08.003 – volume: 28 start-page: 15 year: 2006 ident: 10.3349/ymj.2010.51.5.708_ref2 publication-title: Head Neck doi: 10.1002/hed.20319 – volume: 14 start-page: 2393 year: 2000 ident: 10.3349/ymj.2010.51.5.708_ref38 publication-title: Genes Dev doi: 10.1101/gad.813200 – volume: 52 start-page: 338 year: 2003 ident: 10.3349/ymj.2010.51.5.708_ref14 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-002-0353-8 – volume: 37 start-page: 379 year: 2005 ident: 10.3349/ymj.2010.51.5.708_ref23 publication-title: Exp Mol Med doi: 10.1038/emm.2005.48 – volume: 4 start-page: 859 year: 2002 ident: 10.3349/ymj.2010.51.5.708_ref40 publication-title: Nat Cell Biol doi: 10.1038/ncb868 – volume: 129 start-page: 279 year: 2006 ident: 10.3349/ymj.2010.51.5.708_ref35 publication-title: Methods Mol Med – volume: 36 start-page: 236 year: 2000 ident: 10.3349/ymj.2010.51.5.708_ref3 publication-title: Oral Oncol doi: 10.1016/S1368-8375(99)00079-2 – volume: 29 start-page: 696 year: 2001 ident: 10.3349/ymj.2010.51.5.708_ref34 publication-title: Biochem Soc Trans doi: 10.1042/bst0290696 – volume: 45 start-page: 1470 year: 2008 ident: 10.3349/ymj.2010.51.5.708_ref24 publication-title: Mol Immunol doi: 10.1016/j.molimm.2007.08.013 – volume: 69 start-page: 1800 year: 2009 ident: 10.3349/ymj.2010.51.5.708_ref39 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2725 – volume: 191 start-page: 1005 year: 2000 ident: 10.3349/ymj.2010.51.5.708_ref41 publication-title: J Exp Med doi: 10.1084/jem.191.6.1005 – volume: 85 start-page: 107 year: 2009 ident: 10.3349/ymj.2010.51.5.708_ref31 publication-title: Int J Radiat Biol doi: 10.1080/09553000802662595 – volume: 100 start-page: 182 year: 2007 ident: 10.3349/ymj.2010.51.5.708_ref1 publication-title: Alpha Omegan doi: 10.1016/j.aodf.2007.10.014 – volume: 8 start-page: E532 year: 2006 ident: 10.3349/ymj.2010.51.5.708_ref20 publication-title: AAPS J doi: 10.1208/aapsj080363 – volume: 575 start-page: 12 year: 2007 ident: 10.3349/ymj.2010.51.5.708_ref45 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2007.07.039 – volume: 42 start-page: 197 year: 2008 ident: 10.3349/ymj.2010.51.5.708_ref18 publication-title: Mikrobiyol Bul – volume: 33 start-page: 273 year: 2007 ident: 10.3349/ymj.2010.51.5.708_ref19 publication-title: Amino Acids doi: 10.1007/s00726-007-0536-x – volume: 112 start-page: 475 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref21 publication-title: Int J Cancer doi: 10.1002/ijc.20371 – volume: 3 start-page: 424 year: 2005 ident: 10.3349/ymj.2010.51.5.708_ref12 publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2005.01110.x – volume: 103 start-page: 2718 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref22 publication-title: Blood doi: 10.1182/blood-2003-04-1317 – volume: 99 start-page: 3052 year: 2002 ident: 10.3349/ymj.2010.51.5.708_ref15 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.052707699 – volume: 279 start-page: 37201 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref28 publication-title: J Biol Chem doi: 10.1074/jbc.M405594200 – volume: 275 start-page: 25665 year: 2000 ident: 10.3349/ymj.2010.51.5.708_ref29 publication-title: J Biol Chem doi: 10.1074/jbc.M906383199 – volume: 101 start-page: 227 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref7 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2003.11.004 – volume: 3 start-page: 1071 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref43 publication-title: DNA Repair (Amst) doi: 10.1016/j.dnarep.2004.03.034 – volume: 277 start-page: 39760 year: 2002 ident: 10.3349/ymj.2010.51.5.708_ref42 publication-title: J Biol Chem doi: 10.1074/jbc.M200805200 – volume: 73 start-page: 5115 year: 2005 ident: 10.3349/ymj.2010.51.5.708_ref16 publication-title: Infect Immun doi: 10.1128/IAI.73.8.5115-5126.2005 – volume: 40 start-page: 461 year: 2004 ident: 10.3349/ymj.2010.51.5.708_ref26 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2003.09.012 |
SSID | ssj0027102 |
Score | 1.9017687 |
Snippet | Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels of heat... Purpose: Oral squamous carcinoma (OSCC) cells exhibit resistance to chemotherapeutic agent-mediated apoptosis in the late stage of malignancy. Increased levels... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 708 |
SubjectTerms | ADP Ribose Transferases - pharmacology Antineoplastic Agents - pharmacology Apoptosis - drug effects Bacterial Toxins - pharmacology Blotting, Western Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - metabolism Cell Cycle - drug effects Cell Line, Tumor Chromatography, Liquid Cyclin B - metabolism Cyclin-Dependent Kinase 2 - metabolism Drug Resistance, Neoplasm - drug effects E2F1 Transcription Factor - metabolism Electrophoresis Exotoxins - pharmacology HSP70 Heat-Shock Proteins - genetics HSP70 Heat-Shock Proteins - metabolism Humans In Situ Nick-End Labeling Mouth Neoplasms - drug therapy Mouth Neoplasms - metabolism Original Pseudomonas aeruginosa Exotoxin A Tandem Mass Spectrometry Tumor Suppressor Protein p53 - metabolism Virulence Factors - pharmacology 의학일반 |
Title | Pseudomonas aeruginosa Exotoxin A Reduces Chemoresistance of Oral Squamous Carcinoma Cell via Inhibition of Heat Shock Proteins 70 (HSP70) |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20635445 https://www.proquest.com/docview/733986519 https://pubmed.ncbi.nlm.nih.gov/PMC2908850 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001470608 |
Volume | 51 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Yonsei Medical Journal, 2010, 51(5), , pp.708-716 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe2ISFeJr7pxioj8QBIKYk_8vGApqna1CEVKkrF3iwncdawztmSFnX_An81d0laKKoQT4mUcxz5zvb94rvfEfJaw5aTCmEczY10RMhiuNOhk6QRizkzkhvMdx5-8gcT8fFCXuyQVXmrdgCrrdAO60lNyllveXt3DBP-AyJOLqL3d9ffmxgt6fVkL8DU33uwMfmIxYYi_I2_vDoEEcyQO5iC2Rxybn_Fxja1a8tsmwf6dyDlHzvT2UOy37qU9KSxgUdkx9jH5P6wPTR_Qn6OKrNIC7A3XVFtysVlbotK09NlMS-WuaUn9AsSuJqKIn1AAQAcnUqwBlpk9DP0SMe3C43_CGgfSw_Z4lrTvpnN6I9c03M7zeM68AvFB7C20_EUVlk6QgqI3FY0cOmbwXgUuG-fksnZ6df-wGlLMDgJD8O5o1MAVODhmTQTAReucWOPwbyXgrNMGB4wESauECnAohip4mCFzRgm3DIXkB3nz8ieLax5QSgTiWGpYEZDy0REOmaBlMxPQz-Jue93iLsacZW0_ORYJmOmAKegkhQoSaGSlPSUVKCkDnm3bnLTkHP8S_gVqFFdJblCSm28XhbqqlQAHM6hjRdGIENXSlYwzfDsRFsDw6sCzqPQB3e3Q543Ol_3yMDLQ0qjDgk2rGEtgN1tPrH5tGbyZhhlJt2D__i0Q_KgCVzA8LaXZG9eLswR-EPzuEt2pfOtW_9N6NYW_wuBsAgc |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pseudomonas+aeruginosa+Exotoxin+A+Reduces+Chemoresistance+of+Oral+Squamous+Carcinoma+Cell+via+Inhibition+of+Heat+Shock+Proteins+70+%28HSP70%29&rft.jtitle=Yonsei+medical+journal&rft.au=%EB%B0%95%EC%83%81%EB%A1%80&rft.au=%EC%9D%B4%EA%B2%BD%EB%8D%95&rft.au=%EA%B9%80%EC%9A%B1%EA%B7%9C&rft.au=%EA%B8%B8%EC%98%81%EA%B8%B0&rft.date=2010-09-01&rft.pub=%EC%97%B0%EC%84%B8%EB%8C%80%ED%95%99%EA%B5%90%EC%9D%98%EA%B3%BC%EB%8C%80%ED%95%99&rft.issn=0513-5796&rft.eissn=1976-2437&rft.spage=708&rft.epage=716&rft_id=info:doi/10.3349%2Fymj.2010.51.5.708&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_331898 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-5796&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-5796&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-5796&client=summon |